Dr. Farzana Amin, MD, is a distinguished psychiatrist with a profound commitment to delivering exceptional care to her patients. Her passion for integrating the latest innovations in mental health care is evident in her diverse training and expertise.

​

Farzana Amin, M.D. completed her residency in Adult Psychiatry at St. Louis Medical University in Missouri, where she served as Assistant Chief Resident from 2005-2006. At Stanford University, Dr. Amin served as a fellow for the Child and Adolescent Psychiatry Program, from which she graduated in 2008. At Stanford she worked extensively with children diagnosed with Developmental Disorders, Autism Spectrum Disorders and Intellectual Disabilities.

​​​

Dr. Amin  received training at THE KETAMINE TRAINING CENTER under guidance of Dr Philip Wolfson, MD .

Phil Wolfson MD was the Principal Investigator for the MAPS sponsored Phase 2, FDA approved 18-person study of MDMA Assisted Psychotherapy for individuals with significant anxiety due to life threatening illnesses. 

​

Dr. Amin is board-certified by the American Board of Psychiatry and Neurology (ABPN) in both adult and child and adolescent psychiatry, as well as by the American Board of Obesity Medicine (ABOM). This unique combination of certifications underscores her specialization in Metabolic Psychiatry, a field that bridges mental health and metabolic health.

​

Her comprehensive approach to psychiatry is due to her dedication to understand the interplay between metabolic processes and mental health, allowing her to offer holistic and personalized care to her patients. 

 

With a focus on continuous learning and application of innovative therapies so that her patients receive the most effective and compassionate care available. 

​

COMING SOON:  METABOMIND.COM   APP

​

MetaboMind is a clinician-friendly digital companion designed to help mental health services address the “whole-patient” burden of cardiometabolic risk by pairing metabolic health tracking (weight/waist, BP, glycemic markers, lipids, sleep, activity, nutrition patterns) with standard mental health symptom check-ins and tailored, guideline-concordant lifestyle prompts.

 

By making the bidirectional links between metabolic status, inflammation, and brain function visible over time—and translating those data into practical, incremental goals—MetaboMind supports care teams and patients in aiming for metabolic health not only to protect the body, but also to support cognitive and emotional resilience

 

Poorer metabolic profiles are associated with higher anxiety/depressive symptom burden in some populations, and that nutrition-pattern interventions such as intermittent fasting are under active study for potential neuroinflammatory and neurotrophic effects).